From May 13-17, the Caszyme team – CEO Monika Paule, CSO Giedrius Gasiunas, and Business Development Director Donatas Staniulis – will be joining gene and cell therapy professionals for the 28th Annual ASGCT Meeting in New Orleans!
Don’t miss a chance to learn more about our latest research on the CRISPR-Cas12l genome editor during the Wednesday Poster session on May 14 at 5:30 – 7:00 PM (Poster #1144).
We’re looking forward to meaningful discussions around CRISPR applications and potential collaboration opportunities.